The new biopharma and cell culture will provide customers with access to raw materials including nucleotides, nucleosides, and bio-buffers, as well as cell culture media ingredients like amino acids and vitamins that further support the needs of biopharmaceutical manufacturers. Customers will have greater access to raw materials such as ingredients for hybridoma and Chinese hamster ovary cell culture media.

The offering will be built on the established expertise of Pharma Waldhof, one of the company's facilities located in Düsseldorf, Germany; that facility develops and commercializes active ingredients, key intermediates, excipients, and reagents for multiple life science industries, including pharmaceuticals and diagnostics.

The expanded portfolio will leverage Pharma Waldhof's manufacturing and distribution capabilities, filling and packing, and experience as a worldwide supplier.